← Back to Search

TENS for Chronic Pain

N/A

Recruiting

Led By Guillaume Léonard, PhD

Research Sponsored by Université de Sherbrooke

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Being off work completely due to a musculoskeletal injury

Being 55 years of age or older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4 months

Awards & highlights

Study Summary

This trial is testing whether a remote rehabilitation intervention combining therapeutic exercises and electrical nerve stimulation (TENS) can help people aged 55 and over who have stopped working due to pain. Different feasibility indicators and clinical measures will be used to evaluate the effect of the intervention.

Who is the study for?

This trial is for individuals aged 55 or older who are off work due to musculoskeletal injuries, starting physical rehab, and can handle basic tech like video calls and texts. They should speak French, have stable medication routines, mild to moderate pain during movement, and not have used TENS before.Check my eligibility

What is being tested?

The study tests if combining therapeutic exercises with real or placebo TENS via telerehabilitation helps in work rehabilitation for older adults. It's a triple-blind study where neither participants nor researchers know who gets the real treatment until after the results.See study design

What are the potential side effects?

TENS is generally safe but may cause skin irritation at the electrode sites or muscle twitching. Some people might feel uncomfortable sensations from the electrical current.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am currently not working due to a musculoskeletal injury.

Select...

I am 55 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 4 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~4 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adherence rate

Attrition rate

Exclusion rate

+3 more

Secondary outcome measures

Disability in work Rehabilitation

Overall treatment satisfaction

Pain catastrophizing

+5 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Intervention groupExperimental Treatment1 Intervention

Real TENS and personalized exercise program in telerehabilitation (3 sessions/week over 3 weeks) n = 12

Group II: Control groupPlacebo Group1 Intervention

Simulated TENS and personalized exercise program in telerehabilitation (3 sessions/week over 3 weeks) n = 12

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

TENS

2011

Completed Phase 2

~2040

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Réseau québécois de recherche sur le vieillissement (RQRV)UNKNOWN

1 Previous Clinical Trials

32 Total Patients Enrolled

Université de SherbrookeLead Sponsor

292 Previous Clinical Trials

69,417 Total Patients Enrolled

11 Trials studying Chronic Pain

1,124 Patients Enrolled for Chronic Pain

Réseau Provincial De Recherche En Adaptation-Réadaptation (REPAR)UNKNOWN

1 Previous Clinical Trials

37 Total Patients Enrolled

Media Library

TENS Clinical Trial Eligibility Overview. Trial Name: NCT05316623 — N/A

Chronic Pain Research Study Groups: Control group, Intervention group

Chronic Pain Clinical Trial 2023: TENS Highlights & Side Effects. Trial Name: NCT05316623 — N/A

TENS 2023 Treatment Timeline for Medical Study. Trial Name: NCT05316623 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What aims does this clinical trial seek to achieve?

"The primary purpose of this 4-month clinical trial is to measure refusal rate. Secondary goals include assessing pain intensity using the Visual Analog Scale (VAS, range 0 - 100), the severity and effect on physical functioning with the Brief Pain Inventory (BPI) and qualitatively gauging pain levels by way of McGill Pain Questionnaire's 20 questions for a score ranging from 0 - 78."

Answered by AI

Are there any available vacancies in this clinical research program?

"According to clinicaltrials.gov, this trial is not enrolling patients at present. This study was first hosted on September 1st 2022 and the last update occurred July 27th 2022; however, there are currently 403 other medical trials that require participants' involvement."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Using Peripheral Neurostimulation to Improve Work Rehabilitation

Guillaume Léonard 2023. "Using Peripheral Neurostimulation to Improve Work Rehabilitation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05316623.

All > Chronic Pain